Related Experiment Video

Updated: Jul 30, 2026

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
08:12

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS

Published on: November 26, 2018

Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure

E Mikulic, J N Cohn, J A Franciosa

    Circulation
    |October 1, 1977
    PubMed

    Insights

    Severe congestive heart failure (CHF) patients showed similar cardiac output increases with dobutamine and sodium nitroprusside. Combining these drugs further improved heart function and reduced vascular resistance.

    Area of Science:

    • Cardiology
    • Pharmacology
    • Critical Care Medicine

    Background:

    • Severe congestive heart failure (CHF) management requires optimizing cardiac output and reducing vascular resistance.
    • Intravenous inotropic agents and vasodilators are key therapeutic options for CHF.
    • Understanding the comparative and combined hemodynamic effects of dobutamine and sodium nitroprusside is crucial for treatment strategies.

    Purpose of the Study:

    • To compare the hemodynamic responses to intravenous sodium nitroprusside and dobutamine in patients with severe CHF.
    • To evaluate the combined effects of sodium nitroprusside and dobutamine on cardiac performance and vascular resistance.
    • To investigate the vasodilatory properties of dobutamine and sodium nitroprusside in CHF.

    Main Methods:

    • Hemodynamic parameters were measured in 12 severe CHF patients receiving intravenous sodium nitroprusside or dobutamine.
    • Five additional patients were studied with separate and combined infusions of both drugs.
    • Dose-dependent vasodilation was assessed via brachial arterial infusion.

    Main Results:

    • Both dobutamine and sodium nitroprusside significantly increased cardiac output (CO).
    • Dobutamine resulted in higher arterial pressure and heart rate, with less reduction in pulmonary wedge pressure (PWP) compared to sodium nitroprusside.
    • Combined infusion yielded superior CO, lower PWP, and greater reduction in systemic and pulmonary vascular resistances than either agent alone.

    Conclusions:

    • Potent inotropic and vasodilator drugs like dobutamine and sodium nitroprusside offer additive benefits for left ventricular performance in heart failure.
    • Dobutamine's vasodilation, potentially reflex-mediated, significantly contributes to its positive inotropic effect and cardiac output augmentation.
    • Combination therapy with dobutamine and sodium nitroprusside represents a potent strategy for managing severe heart failure hemodynamics.

    More Related Videos

    Real-time Evaluation of Absolute, Cytosolic, Free Ca2+ and Corresponding Contractility in Isolated, Pressurized Lymph Vessels08:46

    Real-time Evaluation of Absolute, Cytosolic, Free Ca2+ and Corresponding Contractility in Isolated, Pressurized Lymph Vessels

    Published on: March 22, 2024

    Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment08:49

    Cardiac Loading using Passive Left Atrial Pressurization and Passive Afterload for Graft Assessment

    Published on: August 2, 2024

    Related Concept Videos

    Antihypertensive Drugs: Vasodilators01:23

    Antihypertensive Drugs: Vasodilators

    Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
    Heart Failure Drugs: β-Blockers01:22

    Heart Failure Drugs: β-Blockers

    β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
    Antianginal Drugs: Nitrates and β-Blockers01:16

    Antianginal Drugs: Nitrates and β-Blockers

    In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
    Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
    Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

    Antianginal Drugs: Calcium Channel Blockers and Ranolazine

    Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
    CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
    Imbalances in Cardiac Output01:26

    Imbalances in Cardiac Output

    The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
    CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...